Glaukos Corp. (GKOS)
NYSEHealth CareMedical - DevicesSnapshot 2026-09-04
$177.47-1.60%
Close 2026-09-04 · 1-day change
NYSEHealth CareMedical - DevicesSnapshot 2026-09-04
QuarterlyIQ Insights · GKOS
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||
| Revenues | 612.8 | 507.4 | 383.5 | 314.7 | 282.9 | 294.0 | 225.0 | 237.0 | 181.3 | 159.3 | 114.4 | 71.7 |
| Total Revenues | — | — | — | — | — | — | — | — | — | 159.3 | 114.4 | 71.7 |
| Cost of Revenues | 128.0 | 111.8 | 94.0 | 75.6 | 69.0 | 66.6 | 91.7 | 38.6 | 25.1 | — | — | — |
| Gross Profit | 372.0 | 282.8 | 289.5 | 239.1 | 213.9 | 227.4 | 133.2 | 198.4 | 156.2 | 138.2 | 98.2 | 58.7 |
| Operating Expenses & Income | ||||||||||||
| Selling, General & Admin | 386.7 | 331.7 | 261.2 | 224.1 | 192.9 | 179.3 | 171.4 | 176.6 | 119.5 | 96.3 | 64.8 | 44.0 |
| R&D Expenses | — | — | — | — | — | — | — | — | 49.7 | 38.9 | 29.2 | 25.0 |
| Operating Income | (193.4) | (199.6) | (122.4) | (128.7) | (82.3) | (32.9) | (123.6) | (50.3) | (13.0) | (2.3) | 4.2 | (10.3) |
| Earnings from Continuing Operations | ||||||||||||
| Interest Expense | — | — | — | 13.6 | 13.7 | 13.4 | 14.1 | 2.6 | — | — | — | — |
| Interest & Investment Income | — | — | — | — | — | — | — | — | — | — | — | 0.1 |
| Other Non-Operating Income / Expenses | 0.5 | 6.6 | (23.2) | (5.0) | (16.1) | (16.4) | (8.8) | 0.3 | 0.6 | 2.3 | 0.3 | (28.0) |
| EBT, Incl. Unusual Items | (192.8) | (193.0) | (145.6) | (133.7) | (98.4) | (49.3) | (132.3) | (50.0) | (12.4) | 0.0 | 4.6 | (38.3) |
| Income Tax Expense | (4.8) | (5.4) | 0.8 | 0.9 | 0.8 | 0.3 | (12.0) | (65.5) | 0.6 | 0.1 | 0.0 | 0.0 |
| Net Income | ||||||||||||
| Minority Interest | — | — | — | — | — | — | — | — | — | (1.1) | (1.1) | (1.1) |
| Net Income | (188.0) | (187.7) | (146.4) | (134.7) | (99.2) | (49.6) | (120.3) | 15.4 | (13.0) | (0.1) | 4.5 | (37.2) |
| Per Share | ||||||||||||
| Basic EPS | (3.20) | (3.28) | (2.77) | (2.78) | (2.09) | (1.07) | (2.70) | 0.41 | (0.37) | 0.00 | 0.14 | — |
| Diluted EPS | (3.20) | (3.28) | (2.77) | (2.78) | (2.09) | (1.07) | (2.70) | 0.37 | (0.37) | 0.00 | 0.12 | — |
| Revenue per Share | 10.42 | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 58.8 | 57.2 | 52.8 | 48.4 | 47.4 | 46.4 | 44.5 | 37.4 | 35.3 | 34.4 | 32.9 | — |
| Diluted Weighted Avg Shares | 58.8 | 57.2 | 52.8 | 48.4 | 47.4 | 46.4 | 44.5 | 41.1 | 35.3 | 34.4 | 36.5 | — |
| Supplemental | ||||||||||||
| EBITDA | — | (161.5) | (86.7) | (95.0) | (50.7) | (3.2) | (94.2) | (44.0) | (6.7) | 3.2 | 9.0 | (6.0) |
| EBIT | (193.4) | (199.6) | (122.4) | (128.7) | (82.3) | (32.9) | (123.6) | (50.3) | (13.0) | (2.3) | 4.2 | (10.3) |
| Effective Tax Rate | 2.5% | — | — | -0.7% | -0.8% | -0.7% | 9.0% | 130.8% | -4.7% | 9300.0% | 0.9% | -0.1% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.